(CGNX) Cognex - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1924221039
CGNX: Vision Software, Vision Systems, Barcode Readers, Vision Accessories
Cognex Corporation specializes in machine vision technology, offering solutions that enable automation in manufacturing and distribution processes globally. Their products are integral to quality control and logistics, ensuring precision in identifying, inspecting, and tracking items across industries such as automotive, consumer electronics, and pharmaceuticals. The companys portfolio includes VisionPro software for advanced programming, In-Sight vision systems for industrial applications, QuickBuild for streamlined application development, and DataMan for barcode reading. They also provide essential accessories like cameras and lenses, catering to diverse industrial needs.
Based on the provided data, Cognexs stock (NASDAQ:CGNX) shows a mixed outlook. The falling SMA 50 and SMA 200 suggest bearish momentum, while the SMA 20 indicates slight upward movement. The high P/E ratio of 38.71 may signal overvaluation, though the lower forward P/E hints at potential earnings growth. The moderate ATR of 1.37 suggests manageable volatility. In the next three months, CGNX may face challenges due to its high valuation and bearish technical indicators, but could stabilize if earnings expectations are met.
Additional Sources for CGNX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CGNX Stock Overview
Market Cap in USD | 4,624m |
Sector | Technology |
Industry | Scientific & Technical Instruments |
GiC Sub-Industry | Electronic Equipment & Instruments |
IPO / Inception | 1989-07-20 |
CGNX Stock Ratings
Growth Rating | -65.1 |
Fundamental | 14.5 |
Dividend Rating | 24.1 |
Rel. Strength | -38.5 |
Analysts | 3.86/5 |
Fair Price Momentum | 20.46 USD |
Fair Price DCF | 7.71 USD |
CGNX Dividends
Dividend Yield 12m | 0.93% |
Yield on Cost 5y | 0.61% |
Annual Growth 5y | -32.80% |
Payout Consistency | 76.3% |
CGNX Growth Ratios
Growth Correlation 3m | -92.4% |
Growth Correlation 12m | -82.9% |
Growth Correlation 5y | -82.4% |
CAGR 5y | -11.23% |
CAGR/Max DD 5y | -0.15 |
Sharpe Ratio 12m | 0.20 |
Alpha | -46.88 |
Beta | 1.264 |
Volatility | 49.72% |
Current Volume | 2902k |
Average Volume 20d | 3692.9k |
As of May 02, 2025, the stock is trading at USD 27.82 with a total of 2,901,998 shares traded.
Over the past week, the price has changed by +9.29%, over one month by -8.48%, over three months by -31.41% and over the past year by -33.76%.
Neither. Based on ValueRay Fundamental Analyses, Cognex is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 14.45 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CGNX as of May 2025 is 20.46. This means that CGNX is currently overvalued and has a potential downside of -26.46%.
Cognex has received a consensus analysts rating of 3.86. Therefor, it is recommend to buy CGNX.
- Strong Buy: 9
- Buy: 2
- Hold: 10
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, CGNX Cognex will be worth about 23.9 in May 2026. The stock is currently trading at 27.82. This means that the stock has a potential downside of -14.05%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 38.4 | 37.9% |
Analysts Target Price | 47.2 | 69.7% |
ValueRay Target Price | 23.9 | -14.1% |